Kerusso Capital Management LLC Boosts Holdings in The Clorox Company (NYSE:CLX)

Kerusso Capital Management LLC boosted its position in The Clorox Company (NYSE:CLX) by 6.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 19,011 shares of the company’s stock after acquiring an additional 1,148 shares during the quarter. Clorox accounts for about 2.0% of Kerusso Capital Management LLC’s holdings, making the stock its 21st biggest holding. Kerusso Capital Management LLC’s holdings in Clorox were worth $3,097,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of CLX. Nordea Investment Management AB raised its stake in Clorox by 4.5% during the 1st quarter. Nordea Investment Management AB now owns 9,977 shares of the company’s stock valued at $1,519,000 after acquiring an additional 426 shares during the last quarter. Texas Permanent School Fund Corp grew its position in shares of Clorox by 1.8% in the first quarter. Texas Permanent School Fund Corp now owns 25,636 shares of the company’s stock valued at $3,925,000 after purchasing an additional 455 shares during the last quarter. Empirical Finance LLC increased its position in Clorox by 3.5% during the first quarter. Empirical Finance LLC now owns 4,457 shares of the company’s stock worth $682,000 after buying an additional 152 shares in the last quarter. Envestnet Portfolio Solutions Inc. lifted its position in shares of Clorox by 13.3% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 24,567 shares of the company’s stock valued at $3,761,000 after acquiring an additional 2,880 shares in the last quarter. Finally, Empowered Funds LLC boosted its stake in shares of Clorox by 8.4% during the first quarter. Empowered Funds LLC now owns 20,008 shares of the company’s stock valued at $3,063,000 after acquiring an additional 1,558 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Price Performance

NYSE CLX traded up $2.39 during trading on Friday, reaching $165.16. 1,276,258 shares of the company traded hands, compared to its average volume of 1,244,660. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $169.09. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The stock’s 50 day moving average price is $162.14 and its two-hundred day moving average price is $146.83. The company has a market cap of $20.44 billion, a price-to-earnings ratio of 57.55, a P/E/G ratio of 3.02 and a beta of 0.41.

Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period in the prior year, the company posted $0.49 earnings per share. The business’s revenue for the quarter was up 27.0% compared to the same quarter last year. As a group, analysts anticipate that The Clorox Company will post 6.81 EPS for the current year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 2.95%. The ex-dividend date of this dividend was Wednesday, October 23rd. Clorox’s payout ratio is 170.03%.

Insider Activity at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.57% of the company’s stock.

Wall Street Analysts Forecast Growth

CLX has been the subject of several analyst reports. JPMorgan Chase & Co. boosted their price target on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. DA Davidson increased their target price on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Citigroup lifted their price target on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. BNP Paribas raised shares of Clorox to a “strong sell” rating in a research report on Friday, September 6th. Finally, Evercore ISI dropped their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Five equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, Clorox has a consensus rating of “Hold” and a consensus price target of $155.00.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.